[Latin Name]Huperzia serratum

[Source] Huperziceae whole herb from China

[Appearance]Brown to white

[Ingredient]Huperzine A

[Specification]Huperzine A 1% – 5%, HPLC

[Solubility] Soluble in chloroform, methanol, ethanol, slightly soluble in water

[Particle size] 80 Mesh

[Loss on drying] ≤5.0%

[Heavy Metal] ≤10PPM

[Pesticide residue] EC396-2005, USP 34, EP 8.0, FDA

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[What is Huperzine A]

Huperzia is a type of moss that grows in China. It is related to club mosses (the Lycopodiaceae family) and is known to some botanists as Lycopodium serratum . The whole prepared moss was used traditionally. Modern herbal preparations use only the isolated alkaloid known as huperzine A. Huperzine A is an alkaloid found in huperzia that has been reported to prevent the breakdown of acetylcholine, an important substance needed by the nervous system to transmit information from cell to cell. Animal research has suggested that huperzine A’s ability to preserve acetylcholine may be greater than that of some prescription drugs. Loss of acetylcholine function is a primary feature of several disorders of brain function, including Alzheimer’s disease . Huperzine A may also have a protective effect on brain tissue, further increasing its theoretical potential for helping reduce symptoms of some brain disorders.

[Function] Used in alternative medicine, huperzine A has been found to act as a cholinesterase inhibitor, a type of medicine used to prevent the breakdown of acetylcholine (a chemical essential to learning and memory).

Not only used as a treatment for Alzheimer’s disease, huperzine A is also said to enhance learning and memory and to protect against age-related cognitive decline.

In addition, huperzine A is sometimes used to boost energy, increase alertness, and aid in the treatment of myasthenia gravis (an autoimmune disorder that affects the muscles).

PART 2: Deca (Nandrolone Decanoate) or NPP is normally run with a testosterone base. We discuss dosages of Deca and NPP Nandrolone. In Part 1 we covered: What if we run it with NO TESTOSTERONE? What if I megadose it? Will Deca have steroid side effects like bloating? hair loss? loss of libido and sex performance? Should I use HCG to keep my balls full? we tackle these questions as I begin my personal 1.5g per week deca experiment! Subscribe to the channel so you get updates on this cycle.

——————————————————————————————————————————————————————-

****FOR ENTERTAINMENT AND INFORMATIONAL PURPOSES ONLY****

DISCLAIMER : THIS IS NOT APPROVED BY THE FDA TO CURE, PREVENT, TREAT ANY DISEASE. THIS IS NOT MEDICAL, LEGAL OR ANY OTHER TYPE OF ADVICE. SIDE EFFECTS ARE UNKNOWN AND THEREFORE DEATH AND SERIOUS BODILY MAY OCCUR. ONLY EVER USE DRUGS SUPPLEMENTS OR EXERCISE UNDER YOUR DOCTOR DIRECTION.

FOR MORE VIDEOS LIKE THIS SUBSCRIBE TO OUR YOUTUBE CHANNEL.

FOR BEHIND THE SCENES ADD OUR SNAPCHAT

FOR CURRENT UPDATES FOLLOW INSTAGRAM

FOR LIVE Q AND A VIDEOS LIKE OUR PAGE IN FACEBOOK

~~~~~~~~~~~~

STAY SWELL AND SWOLE, FRIENDS OF FREEDOM

FOR CURRENT UPDATES FOLLOW INSTAGRAM

FOR LIVE Q AND A VIDEOS LIKE OUR PAGE IN FACEBOOK

THANK YOU FOR WATCHING ENHANCEDATHELTE.COM

STAY SWELL AND SWOLE, FRIENDS OF FREEDOM!

——————————————————————————————————————————————————————-

HERE IS THE GUY ON THE PHONE: https://www.facebook.com/profile.php?id=100008608656094

His name: Taeian Clark
Let me know if you like his style and I will have him on more

After nine years of trial and error and fighting the current medical philosophy, a mother does the impossible. She finds a treatment for Down Syndrome, reversing the damage and substantially increasing IQ and quality of life. After 2 years of remarkable progress with her own son, she shares her new discovery with other parents and begins a small study. The results are spectacular. Each child is not only learning new skills and abilities but all are experiencing a new social life. The oldest child, at 25, has come back from the world of Alzheimer’s in only eight months. After success with the small group of children, researchers at Stanford University Down Syndrome Research Center, applaud her work and begin the process of clinical trials to prove the efficacy of her new protocol.